China Universal Asset Management Company’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$519K	Buy	22,011 +2,051	+10%	+$52.3K	0.04%	254
2025 Q4	$580K	Sell	19,960 -1,058	-5%	-$27.1K	0.04%	243
2025 Q3	$396K	Sell	21,018 -2,923	-12%	-$46.1K	0.03%	270
2025 Q2	$336K	Buy	23,941 +144	+0.6%	+$2.02K	0.03%	278
2025 Q1	$372K	Sell	23,797 -1,021	-4%	-$14.4K	0.03%	270
2024 Q4	$346K	Buy	24,818 +2,336	+10%	+$25.6K	0.03%	283
2024 Q3	$209K	Buy	22,482 +8,881	+65%	+$87.6K	0.02%	295
2024 Q2	$126K	Sell	13,601 -5,013	-27%	-$45.3K	0.02%	284
2024 Q1	$184K	Buy	18,614 +7,694	+70%	+$57.4K	0.02%	300
2023 Q4	$35.3K	Buy	10,920 +9,330	+587%	+$25.4K	0.01%	396
2023 Q3	$8.44K	Buy	1,590 +785	+98%	+$6.68K	﹤0.01%	357
2023 Q2	$7.67K	Sell	805 -23	-3%	-$255	﹤0.01%	335
2023 Q1	$9.11K	Buy	828 +209	+34%	+$3.02K	﹤0.01%	302
2022 Q4	$9.16K	Buy	619 +56	+10%	+$978	﹤0.01%	236
2022 Q3	$11K	Buy	+563	New	+$12.8K	﹤0.01%	193